Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Change in Cash: 2021-2025

Historic Change in Cash for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to -$15.0 million.

  • ProQR Therapeutics N.V's Change in Cash fell 228.98% to -$15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year increase of 152.79%. This contributed to the annual value of $31.9 million for FY2024, which is 25.04% up from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Change in Cash of -$15.0 million as of Q3 2025, which was down 12.50% from -$13.4 million recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's Change in Cash registered a high of $88.3 million during Q2 2021, and its lowest value of -$59.9 million during Q3 2022.
  • Over the past 3 years, ProQR Therapeutics N.V's median Change in Cash value was -$8.8 million (recorded in 2023), while the average stood at $976,847.
  • Per our database at Business Quant, ProQR Therapeutics N.V's Change in Cash slumped by 431.09% in 2022 and then skyrocketed by 4,264.73% in 2024.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Change in Cash stood at $35.0 million in 2021, then slumped by 111.82% to -$4.1 million in 2022, then soared by 63.18% to -$1.5 million in 2023, then surged by 4,264.73% to $63.4 million in 2024, then plummeted by 228.98% to -$15.0 million in 2025.
  • Its Change in Cash stands at -$15.0 million for Q3 2025, versus -$13.4 million for Q2 2025 and -$17.4 million for Q1 2025.